IHS Chemical Week

Pharma/fine chemicals roundup—28 July 2015

July 28, 2015 | By DEEPTI RAMESH

Lonza's earnings, sales rise on restructuring, firm demand; more job cuts planned at Swiss site Lonza reports a 2.5% increase in net profit for the first half of 2015 compared with the same period last year, to 166 million Swiss francs, on sales up 5.8%, to SF1.9 billion. Operating profit increased 7.9% year-on-year, to SF260 million, and Ebitda rose 6.3%, to SF391 million. Quarterly figures have not been...

Pharma/fine chemicals roundup—14 July 2015

July 14, 2015 | By DEEPTI RAMESH

US pharmaceutical chemicals market to reach $54 billion in 2019 US demand for pharmaceutical chemicals is forecast to rise 6.1%/year to $54 billion in 2019 says a recent market report published by ReportLinker. Merchant market sales primarily to generic drug companies will account for nearly one-third of this total. The remainder of demand will consist of the value of pharmaceutical chemicals produced...

Pharma/fine chemicals roundup—8 July 2015

July 8, 2015 | By DEEPTI RAMESH

FDA issues warning letter to Canada-based firm for violating cGMP for API manufacturing The US FDA issued a warning letter on 22 June to the manufacturing and repackaging facility of Attix Pharmaceuticals—located at Toronto, Canada—for deviations from cGMP for the manufacture of active pharmaceutical ingredients (APIs). The warning letter was published on the FDA Web site earlier this month. An...

Trade agenda moves forward, but don't forget the miscellaneous tariff bill


As we’ve watched TPA and Trade Adjustment Assistance (TAA) pass in both the House and Senate in recent days, we’ve heard little or no mention of the Miscellaneous Tariff Bill, legislation that temporarily suspends a duty on an imported raw material that is not available in the United States....

Pharma/fine chemicals roundup—30 June 2015

June 30, 2015 | By DEEPTI RAMESH

Novasep to build ADC facility in France Novasep (Pompey, France), a supplier of services and technologies for the life sciences and chemical industries, says that it will build a fully integrated antibody drug conjugate (ADC) facility at the company’s site at Le Mans, France. The announcement confirms CW’s exclusive report last year that Novasep is considering building an ADC facility. The new...

Pharma/fine chemicals roundup—23 June 2015

June 23, 2015 | By DEEPTI RAMESH

ScinoPharm signs API manufacturing deal with Raffles PharmaTech Active pharmaceutical ingredient (API) manufacturer ScinoPharm (Tainan, Taiwan) says that it will collaborate with Raffles PharmaTech (Huizhou, China) to manufacture celecoxib, a nonsteroidal and anti-inflammatory analgesic API. Raffles is focused on organic macromolecule catalysts, value-added pharmaceutical intermediates, and APIs, and its...

Pharma/fine chemicals roundup—16 June 2015

June 16, 2015 | By DEEPTI RAMESH

BPTF seeks changes in performance goals, fee payment schedule in GDUFA renegotiations The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Socma, has asked the US FDA to consider several changes to performance goals and the fee payment schedule prior to reauthorization of the Generic Drug User Fee Act (GDUFA). BPTF made its requests during a public meeting at White Oak, MD. BPTF, representing...

Pharma/fine chemicals roundup—9 June 2015

June 9, 2015 | By DEEPTI RAMESH

FDA issues warning letter to API plant in Czech Republic The US FDA issued a warning letter on 27 May to the active pharmaceutical ingredient (API) manufacturing facility of Vuab Pharma—located at Roztoky, Czech Republic—for violating cGMP. The warning letter was published on the FDA Web site on 2 June. An FDA inspection from 9-13 June 2014 at the Roztoky facility identified significant...

In pricing chemicals, crude's falling cost requires a refined response

June 2, 2015 | By MITCH LEE

The situation: Brent crude oil costs have more than halved since mid-2014, causing the PPI inflation rate for chemical products to fall from 1.7% year over year in November 2014 to -2.1% year over year in December. This generous reprieve is expected to hold for the next 12 months. The question: Should chemical companies drop their prices? Customers say “yes,” while chemical companies are well...

Pharma/fine chemicals roundup—2 June 2015

June 2, 2015 | By DEEPTI RAMESH

AbbVie completes $21-billion acquisition of cancer drugs producer Pharmacyclics AbbVie (Chicago) says that it has completed the previously announced acquisition of Pharmacyclics (Sunnyvale, CA), a pharmaceutical company that focuses on small-molecule drugs for treating cancer and immune-mediated diseases, in a deal valued at $21 billion. Pharmacyclics will be a wholly owned subsidiary of AbbVie and will...


Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact rob.westervelt@ihs.com.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis from the entire global chemical enterprise on chemweek.com
  • Free mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa